Disease Modifying Therapy in Multiple Sclerosis
- PMID: 27355035
- PMCID: PMC4897446
- DOI: 10.1155/2014/307064
Disease Modifying Therapy in Multiple Sclerosis
Abstract
Multiple sclerosis is an autoimmune disease of the central nervous system characterized by inflammatory demyelination and axonal degeneration. It is the commonest cause of permanent disability in young adults. Environmental and genetic factors have been suggested in its etiology. Currently available disease modifying drugs are only effective in controlling inflammation but not prevention of neurodegeneration or accumulation of disability. Search for an effective neuroprotective therapy is at the forefront of multiple sclerosis research.
Similar articles
-
Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.J Neurol. 2005 Nov;252 Suppl 5:v38-45. doi: 10.1007/s00415-005-5007-2. J Neurol. 2005. PMID: 16254701 Review.
-
Neuronal injury in chronic CNS inflammation.Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review.
-
Axonal pathology in multiple sclerosis: relationship to neurologic disability.Curr Opin Neurol. 1999 Jun;12(3):295-302. doi: 10.1097/00019052-199906000-00008. Curr Opin Neurol. 1999. PMID: 10499174 Review.
-
Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.J Neuroinflammation. 2017 Mar 17;14(1):57. doi: 10.1186/s12974-017-0831-8. J Neuroinflammation. 2017. PMID: 28302146 Free PMC article.
-
Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.Pharmacol Ther. 2010 Apr;126(1):82-93. doi: 10.1016/j.pharmthera.2010.01.006. Epub 2010 Feb 1. Pharmacol Ther. 2010. PMID: 20122960 Review.
Cited by
-
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy.J Clin Med. 2023 Nov 19;12(22):7175. doi: 10.3390/jcm12227175. J Clin Med. 2023. PMID: 38002787 Free PMC article.
-
Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis.J Clin Med. 2020 Nov 22;9(11):3766. doi: 10.3390/jcm9113766. J Clin Med. 2020. PMID: 33266435 Free PMC article.
-
Prioritizing Components of a Dyadic Physical Activity Intervention for People With Moderate to Severe Multiple Sclerosis and Their Care Partners: A Modified e-Delphi Study.Int J MS Care. 2023 Jan-Feb;25(1):8-14. doi: 10.7224/1537-2073.2021-079. Epub 2022 Jul 5. Int J MS Care. 2023. PMID: 36711219 Free PMC article.
-
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration.Diagnostics (Basel). 2022 May 6;12(5):1156. doi: 10.3390/diagnostics12051156. Diagnostics (Basel). 2022. PMID: 35626311 Free PMC article.
-
Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy.J Clin Med. 2025 Aug 21;14(16):5919. doi: 10.3390/jcm14165919. J Clin Med. 2025. PMID: 40869745 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources